Drug intelligence / Profile preview

umbilical cord mesenchymal stem cells (Universitas Indonesia)

Development stage
Unknown
Lead developer
Universitas Indonesia
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intracoronary
01

Overview

Umbilical cord mesenchymal stem cells (UC-MSCs) are multipotent stromal cells harvested from umbilical cord tissue, currently being evaluated by Indonesia University for the treatment of ST-elevation myocardial infarction (STEMI). These cells are administered via intracoronary injection approximately 10-15 days after primary percutaneous coronary intervention (PCI). The therapeutic mechanism is primarily paracrine, involving the secretion of various cytokines and growth factors that promote angiogenesis, exert anti-inflammatory effects, and reduce cardiomyocyte apoptosis. The clinical objective is to reduce myocardial infarct size, reverse adverse ventricular remodeling, and prevent the progression to heart failure.

Other names
UC-MSCallogenic umbilical cord mesenchymal stem cellsUmbilical Cord Mesenchymal Stem Cell transplantation

Beyond the preview

Go deeper on umbilical cord mesenchymal stem cells (Universitas Indonesia).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord mesenchymal stem cells (Universitas Indonesia).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call